We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current JNJB34 market cap is 1.61B. The company's latest EPS is USD 1282.7923 and P/E is 0.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.49B | 21.4B | 21.38B | 22.45B | 22.47B |
| Operating Income | 3.86B | 4.19B | 5.91B | 6.28B | 5.04B |
| Net Income | 26.03B | 4.05B | 3.26B | 4.69B | 2.69B |
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.06B | 82.58B | 93.78B | 94.94B | 85.16B |
| Operating Income | 19.81B | 19.49B | 23.4B | 23.38B | 21.21B |
| Net Income | 15.12B | 14.71B | 20.88B | 17.94B | 35.15B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 166.06B | 167.56B | 171.97B | 181.09B | 178.29B |
| Total Liabilities | 94.83B | 98.78B | 101.95B | 109.55B | 108.13B |
| Total Equity | 71.23B | 68.77B | 70.02B | 71.54B | 70.16B |
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 157.73B | 174.89B | 182.02B | 187.38B | 167.56B |
| Total Liabilities | 98.26B | 111.62B | 108B | 110.57B | 98.78B |
| Total Equity | 59.47B | 63.28B | 74.02B | 76.8B | 68.77B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 14.93B | 22.79B | 3.66B | 9.29B | 17.28B |
| Investing | 2.08B | 878M | -464M | -14.15B | -17.28B |
| Financing | -11.17B | -15.83B | 546M | 8.09B | -1.79B |
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 23.42B | 23.54B | 23.41B | 21.19B | 22.79B |
| Investing | -6.19B | -20.83B | -8.68B | -12.37B | 878M |
| Financing | -18.02B | -6.12B | -14.05B | -8.87B | -15.83B |
| Market Cap | 1.61B |
| Price to Earnings Ratio | 0.11 |
| Price to Sales Ratio | 0.05 |
| Price to Cash Ratio | 0.18 |
| Price to Book Ratio | 0.06 |
| Dividend Yield | 3.17% |
| Shares Outstanding | 27.4M |
| Average Volume (1 week) | 11.72k |
| Average Volume (1 Month) | 12.4k |
| 52 Week Change | 15.79% |
| 52 Week High | 63.86 |
| 52 Week Low | 49.65 |
| Spread (Intraday) | 1 (1.69%) |
| Company Name | Johnson & Johnson |
| Address |
one johnson & johnson plaza new brunswick, new jersey 08933 |
| Website | https://www.jnj.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
